Dafodil Bioprosthetic Aortic Valve

The tri-leaflet design mimics native valve function, promoting laminar flow and reducing turbulence. The Elgiloy backbone provides superior radial strength and fatigue resistance, ensuring consistent leaflet coaptation and minimizing paravalvular leakage, thereby enhancing hemodynamic performance and precision.

The Anti Ca™ treatment is a proprietary process designed to mitigate calcium binding within the bovine pericardial leaflets. By reducing calcification, the treatment enhances biocompatibility, minimizes leaflet stiffening, and ultimately prolongs the functional lifespan and durability of the bioprosthesis.

The broad range of sizes allows for precise anatomical matching in a diverse patient population. This facilitates optimal valve selection, potentially simplifying implantation, reducing the risk of patient-prosthesis mismatch, and improving overall surgical outcomes.

This product is manufactured by Meril Life Sciences and is distributed by Agile Healthcare across all districts of Telangana.

Yes, all Meril Life Sciences products distributed by Agile Healthcare, including the Dafodil Bioprosthetic Aortic Valve, strictly adhere to CDSCO guidelines and ISO 13485:2016 quality standards.

The Dafodil Bioprosthetic Aortic Valve is constructed using Bovine pericardium, ensuring high biocompatibility and durability.